Insider Trading March 30, 2026

Halliburton CEO Executes $6.34M Stock Sale as Company Posts Operational and Analyst Momentum

Jeffrey Miller sold 158,455 shares under a pre-arranged trading plan while the company reports an automated well-placement milestone and receives analyst upgrades

By Hana Yamamoto HAL
Halliburton CEO Executes $6.34M Stock Sale as Company Posts Operational and Analyst Momentum
HAL

Halliburton Chief Executive Jeffrey Allen Miller sold 158,455 shares of common stock on March 27, 2026, for roughly $6.34 million, according to a filing. The transaction took place as the stock traded close to a 52-week high, with recent analyst moves and a technical milestone for offshore well placement drawing investor attention.

Key Points

  • CEO Jeffrey Allen Miller sold 158,455 shares on March 27, 2026, at $40.00 per share for $6.34 million while still holding over 1.01 million shares.
  • Halliburton reported the industry’s first fully automated geological well placement offshore Guyana in collaboration with ExxonMobil, Sekal, Noble and the Wells Alliance Guyana team.
  • Analyst actions include Evercore ISI upgrading Halliburton to Outperform and raising its price target to $42.00; BMO Capital also raised its target to $42 while keeping a Market Perform rating.

Halliburton Co. (NYSE: HAL) reported an insider sale by Director, President and CEO Jeffrey Allen Miller, who disposed of 158,455 shares of common stock on March 27, 2026, at a price of $40.00 per share, for a total consideration of approximately $6.34 million.


The sale occurred while Halliburton shares were trading near their 52-week high of $40.43, following a 66% rally over the prior 12 months. After completing the transaction, Miller continues to directly hold 1,013,027.02 shares of Halliburton common stock.

Miller also retains existing option holdings in the company: options to acquire 128,500 shares with an exercise price of $43.38 expiring December 6, 2027; and options to acquire 69,500 shares with an exercise price of $53.54 expiring December 7, 2026. The sale was carried out pursuant to a pre-arranged Rule 10b5-1 trading plan that Miller adopted on February 13, 2025.


Separately, the company disclosed an operational milestone: Halliburton said it completed the industry’s first fully automated geological well placement offshore Guyana. The project was executed in collaboration with ExxonMobil, Sekal, Noble and the Wells Alliance Guyana team and employed technologies aimed at rig automation and precise well placement.

Analyst activity around the stock has picked up as well. Evercore ISI upgraded Halliburton’s rating to Outperform and lifted its price target to $42.00 from $36.00, citing the company’s positioning to benefit from U.S. onshore activity. BMO Capital raised its price target to $42 from $39 while maintaining a Market Perform rating, noting this stance despite ongoing geopolitical disruptions.

In related coverage of the oilfield services sector, Evercore ISI also upgraded Helmerich & Payne to Outperform from In Line and increased its price target to $43.00 from $37.00, pointing to Helmerich & Payne’s position to capture U.S. onshore drilling activity and expectations for 35 rigs to return to work in 2026.


Market-wide factors were also referenced: geopolitical tensions have caused disruptions in the Middle East that affected oil production and contributed to crude price volatility. Bank of America has communicated a favorable long-term view on North American oilfield services, even as current geopolitical developments create near-term challenges.

According to InvestingPro analysis referenced in the filing, Halliburton’s shares appear fairly valued at current levels. The company is noted to have maintained dividend payments for 56 consecutive years. The InvestingPro note also referenced additional proprietary content and metrics available on its platform.


This filing and the accompanying operational and analyst developments provide multiple data points for investors assessing Halliburton’s positioning, capital allocation by insiders, and the broader oilfield services backdrop.

Risks

  • Ongoing geopolitical tensions in the Middle East have disrupted oil production and contributed to volatility in crude prices, which may affect oilfield services demand.
  • Analyst outlooks and price-target revisions vary across firms, introducing uncertainty for investor expectations and market valuation.
  • Market movements near the stock’s 52-week high could increase sensitivity to price fluctuations and insider transactions.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026